Royal Bank Of Canada Gossamer Bio, Inc. Transaction History

Royal Bank Of Canada

  • $579 Billion
  • Q3 2025

A detailed history of Royal Bank Of Canada transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 1,001,606 shares of GOSS stock, worth $2.71 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,001,606
Previous 82,199 1118.51%
Holding current value
$2.71 Million
Previous $101,000 2507.92%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
BUY
$1.21 - $3.46 $1.11 Million - $3.18 Million
919,407 Added 1118.51%
1,001,606 $2.63 Million
Q2 2025

Nov 21, 2025
BUY
$0.78 - $1.44 $63,517 - $117,263
81,433 Added 10630.94%
82,199 $101,000
Q2 2025

Aug 14, 2025
BUY
$0.78 - $1.44 $63,517 - $117,263
81,433 Added 10630.94%
82,199 $101,000
Q1 2025

Nov 21, 2025
SELL
$0.85 - $1.53 $850,714 - $1.53 Million
-1,000,840 Reduced 99.92%
766 $0
Q1 2025

May 15, 2025
SELL
$0.85 - $1.53 $628 - $1,130
-739 Reduced 49.1%
766 $0
Q4 2024

Feb 14, 2025
SELL
$0.66 - $1.07 $1,218 - $1,975
-1,846 Reduced 55.09%
1,505 $1,000
Q3 2024

Nov 14, 2024
SELL
$0.79 - $1.25 $206 - $327
-262 Reduced 7.25%
3,351 $3,000
Q2 2024

Aug 14, 2024
BUY
$0.51 - $1.27 $236 - $588
463 Added 14.7%
3,613 $3,000
Q1 2024

Nov 05, 2024
SELL
$0.8 - $1.51 $370 - $699
-463 Reduced 12.81%
3,150 $3,000
Q1 2024

May 15, 2024
SELL
$0.8 - $1.51 $52 - $99
-66 Reduced 2.05%
3,150 $3,000
Q4 2023

Feb 14, 2024
BUY
$0.48 - $1.08 $31 - $71
66 Added 2.1%
3,216 $2,000
Q3 2023

Nov 14, 2023
SELL
$0.78 - $1.82 $167 - $391
-215 Reduced 6.39%
3,150 $2,000
Q2 2023

Aug 14, 2023
SELL
$0.98 - $1.53 $8,003 - $12,495
-8,167 Reduced 70.82%
3,365 $4,000
Q1 2023

May 15, 2023
SELL
$0.96 - $2.92 $5,485 - $16,684
-5,714 Reduced 33.13%
11,532 $14,000
Q4 2022

Feb 14, 2023
BUY
$1.74 - $12.87 $27,180 - $201,042
15,621 Added 961.29%
17,246 $37,000
Q3 2022

Nov 14, 2022
BUY
$7.21 - $14.88 $8,039 - $16,591
1,115 Added 218.63%
1,625 $19,000
Q2 2022

Aug 15, 2022
SELL
$5.97 - $9.97 $39,413 - $65,821
-6,602 Reduced 92.83%
510 $4,000
Q1 2022

May 16, 2022
SELL
$8.44 - $12.49 $38,300 - $56,679
-4,538 Reduced 38.95%
7,112 $61,000
Q4 2021

Feb 14, 2022
BUY
$10.12 - $14.07 $58,928 - $81,929
5,823 Added 99.93%
11,650 $132,000
Q3 2021

Nov 15, 2021
SELL
$7.25 - $13.23 $377,384 - $688,661
-52,053 Reduced 89.93%
5,827 $73,000
Q2 2021

Aug 16, 2021
BUY
$8.0 - $9.75 $463,040 - $564,330
57,880 New
57,880 $470,000

Others Institutions Holding GOSS

# of Institutions
181
Shares Held
163M
Call Options Held
8.11M
Put Options Held
211K
View Full List

About Gossamer Bio, Inc.

GOSS Quotes by TradingView
  • Ticker GOSS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,954,000
  • Market Cap $255M
  • Description
  • Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...
More about GOSS
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email